Imatinib was developed by Novartis. It was first approved for marketing by the US Food and Drug Administration (FDA) on May 10, 2001, and then approved for marketing by the European Medicines Agency (EMA) on November 7, 2001. On March 9, it was approved for marketing by the Japan Pharmaceuticals and Medical Devices Agency (PMDA). It is marketed in the United States by Novartis (trade name: Gleevec). Visit us to know Imatinib price in Philippines, USA, UK
https://www.medixocentre.com/gleevec-imatinib-cost
https://www.medixocentre.com/gleevec-imatinib-cost
Imatinib was developed by Novartis. It was first approved for marketing by the US Food and Drug Administration (FDA) on May 10, 2001, and then approved for marketing by the European Medicines Agency (EMA) on November 7, 2001. On March 9, it was approved for marketing by the Japan Pharmaceuticals and Medical Devices Agency (PMDA). It is marketed in the United States by Novartis (trade name: Gleevec). Visit us to know Imatinib price in Philippines, USA, UK
https://www.medixocentre.com/gleevec-imatinib-cost
0 Comments
0 Shares
336 Views